Scientific article
English

Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection

Published in

Reviews on recent clinical trials, vol. 9, no. 3, p. 204-209

Publication date

2014

Abstract

Due to their high prevalence, non-alcoholic fatty liver disease (NAFLD), insulin resistance (IR) and hepatitis C virus (HCV) infection are bound to cohabit. However, the relationship between these 3 entities is complex and multilayered. HCV, particularly genotype 3, may induce a "viral" steatosis, morphologically indistinguishable from the steatosis of NAFLD but with different implications and prognosis. On the other hand, epidemiological and experimental data show that patients with HCV have a higher risk of developing IR and, in susceptible individuals, type 2 diabetes (T2D). In patients with HCV, T2D increases fibrosis progression rate, increases the incidence of HCC, worsens liver-related outcomes and worsens response to interferon-α based therapy. We conclude by discussing a possible increased incidence of cardiovascular events in HCV patients.

Citation (ISO format)

GOOSSENS, Nicolas, NEGRO, Francesco. Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection. In: Reviews on recent clinical trials, 2014, vol. 9, n° 3, p. 204–209. doi: 10.2174/1574887109666141216101939

Identifiers

Journal ISSN

1574-8871
582views
0downloads

Technical informations

Creation

30/03/2015 15:15:00

First validation

30/03/2015 15:15:00

Update

14/03/2023 23:05:45

Status update

14/03/2023 23:05:45

Last indexation

30/10/2024 23:42:02
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated